Today: 11 June 2026
Exxon Mobil (XOM) Stock After Hours on Dec. 22, 2025: Oil Rebounds, XOM Edges Higher Late, and Key Catalysts Before Tuesday’s Open
23 December 2025
5 mins read

Exxon Mobil (XOM) Stock After Hours on Dec. 22, 2025: Oil Rebounds, XOM Edges Higher Late, and Key Catalysts Before Tuesday’s Open

Exxon Mobil Corporation (NYSE: XOM) ended Monday’s regular session in positive territory—and, importantly for traders watching extended hours, the stock stayed calm after the closing bell as energy markets reacted to fresh geopolitical headlines.

XOM finished Dec. 22, 2025 at $118.15, up 1.25% on the day, with the stock trading in a relatively tight $117.34–$118.46 range.

In the after-hours session, Exxon shares were slightly higher, trading at $118.23 at 6:00 p.m. ET—a +0.07% move from the regular close—after touching $118.24 (high) and $118.00 (low) in extended trading.

With Tuesday’s (Dec. 23) open approaching in a holiday-shortened week, here’s what today’s news flow and fresh analysis suggest investors should keep on their radar.


What happened to Exxon Mobil stock today (regular session)

Exxon’s Monday move was steady rather than explosive. The stock’s +1.25% rise came alongside gains in the broader market, with the S&P 500 up 0.64% and the Dow up 0.47% by the close.

A few additional takeaways from today’s tape:

  • Volume was light versus recent norms: about 11.6 million shares traded, which MarketWatch flagged as below the 50-day average.
  • Relative performance vs peers was mixed. MarketWatch noted Exxon gained, but underperformed Chevron (+1.39%) and ConocoPhillips (+1.49%) on the day.
  • The stock remains near its highs. Exxon ended the session about 2.2% below its 52-week high of $120.81 (per MarketWatch’s comparison note).

That “near-the-highs” positioning matters because, in late December, thin liquidity can amplify reactions—especially when the key driver is crude oil sentiment, not a company-specific earnings catalyst.


After-hours check: calm trade, slight upside bias

After the bell, XOM didn’t show the kind of sharp repricing you’d normally associate with surprise corporate headlines.

As of 6:00 p.m. ET, Public.com data showed:

  • After-hours price:$118.23
  • Change vs close:+ $0.08 (+0.07%)
  • After-hours range:$118.00–$118.24

In other words: no “new information shock” hit the tape late Monday. If XOM is going to gap meaningfully Tuesday morning, the more likely drivers are oil futures, overnight geopolitical updates, or macro data at 8:30 a.m. ET.


The biggest catalyst today: oil prices climbed on Venezuela-related enforcement news

Energy investors didn’t have to look far for a macro reason behind Monday’s bid in the sector.

Reuters reported oil prices rose Monday after the U.S. intercepted an oil tanker near Venezuela, reinforcing the market’s perception of tighter sanctions enforcement. Reuters cited Brent up to around $60.99 and WTI around $57.02 during the session.

By late afternoon, MarketWatch’s front-month WTI futures snapshot showed crude higher in the high-$57 area (example: Feb 2026 WTI near $57.95 around 4:58 p.m. ET).

This matters for Exxon because—even with a diversified downstream and chemicals footprint—upstream earnings power remains highly sensitive to crude and product pricing. When oil catches a geopolitical bid, integrated majors often follow.

Reuters also noted that energy was among the leading S&P 500 sectors in Monday’s session—consistent with the oil tape turning supportive.

The “bigger picture” oil debate: geopolitics vs oversupply

One reason Exxon (and the entire energy complex) can feel “headline-driven” is that the market is juggling two competing narratives:

  • Geopolitical disruption risk (Venezuela enforcement, Russia-Ukraine risks, shipping routes, sanctions)
  • Structural oversupply concerns and a market that can absorb shocks more easily than it used to

Reuters published analysis today arguing that oil’s “geopolitical premium” has been muted in 2025 even amid major events—suggesting the market may be operating with a larger “energy abundance” cushion. Reuters
Reuters also pointed to China’s role in influencing oil pricing via stockpiling and inventory behavior—potentially competing with OPEC+ as a price-setting force. Reuters

For Exxon shareholders, that macro backdrop is crucial: it can help explain why XOM can trade resiliently even when oil isn’t surging, but also why sudden crude spikes may fade quickly if the market believes supply remains ample.


Today’s Exxon-specific headlines: Trinidad exploration timing and Guyana project supply chain

While oil prices set the tone, Exxon also appeared in notable company-focused items today—mainly tied to its long-cycle growth engines.

1) Trinidad and Tobago: seismic survey timeline pulled forward

A Zacks Equity Research report (published Monday) said Exxon plans to begin a seismic survey offshore Trinidad and Tobago as early as February 2026, after securing an exploration contract earlier in 2025 for a large offshore block.

If confirmed through permitting and execution, this is the kind of early-stage activity that doesn’t move tomorrow’s open by itself—but it contributes to the longer-term narrative that Exxon continues to refresh its exploration pipeline alongside more mature cash generators.

2) Guyana: Hammerhead subsea system contract (via NOV) highlights development runway

Another Zacks item Monday focused on NOV Inc. winning work connected to Exxon’s Hammerhead development offshore Guyana, describing an actively heated flexible pipe system and framing Hammerhead as a future project expected to start production later in the decade.

The Guyana angle remains strategically important for Exxon’s equity story because Stabroek is widely viewed as one of the world’s most advantaged new oil provinces. Separately, Chevron’s 2025 Hess acquisition established Chevron as the owner of Hess’s former stake in the Stabroek Block—an ownership shift that reshaped the partnership landscape last year.


Forecasts and analyst expectations (today): what the Street is modeling for XOM

Monday’s post-close research coverage offered updated expectations and a reminder of what the next earnings checkpoint looks like.

Earnings timing

Multiple market listings point to Jan. 30, 2026 as Exxon’s next scheduled earnings date.

Consensus figures highlighted today

Zacks’ post-close note summarized current consensus estimates as follows:

  • Next quarter: earnings around $1.63 per share on revenue around $85.13B
  • Full year: earnings around $6.89 per share on revenue around $333.31B

Analyst rating / price target snapshot (as of today)

Public.com’s compiled analyst snapshot shows:

  • Consensus rating:Buy
  • Analyst count:17
  • Consensus price target:$130.12 (as displayed)

Treat any single “price target” as a directional sentiment gauge rather than a near-term predictor—especially in a week where macro headlines can overwhelm company-specific modeling.


What to watch before the market opens Tuesday, Dec. 23, 2025

Here are the catalysts most likely to matter between tonight and Tuesday’s opening bell—especially for a stock like Exxon where macro inputs can quickly dominate.

1) Oil futures and Venezuela/Russia-Ukraine headline flow

Monday’s lift in crude was tied to enforcement actions near Venezuela and broader geopolitics.
If that story escalates overnight—or if traders fade the move on oversupply expectations—XOM’s premarket tone can change quickly.

2) Key U.S. economic data at 8:30 a.m. ET

Macro prints matter for energy because they feed expectations for growth, rates, and ultimately demand.

BEA schedule updates indicate GDP (Q3) and Corporate Profits (preliminary) are scheduled for release Tuesday, Dec. 23 at 8:30 a.m. ET.
Reuters also flagged attention on upcoming economic data (including GDP) during this holiday-shortened week.

A “hotter” growth print can support cyclicals and energy on demand optimism, while a weaker print can pressure crude and energy equities—though the reaction often depends on what markets infer about interest rates.

3) Holiday trading mechanics: lighter liquidity and early close ahead

Tuesday is a normal session, but the calendar context still matters.

The NYSE holiday calendar notes an early close at 1:00 p.m. ET on Wednesday, Dec. 24, 2025.
Reuters also reported exchanges would close early on Dec. 24 as previously planned.

Lower liquidity around holiday weeks can mean:

  • Wider bid/ask spreads, especially premarket/after-hours
  • Bigger swings on smaller headlines
  • Sector-level moves (like energy reacting to crude) becoming more pronounced

4) Energy inventory reporting may be disrupted

Normally, traders watch weekly inventory data as a near-term oil catalyst. But the schedule may not be standard this week.

EIA’s Weekly Petroleum Status Report page notes a schedule change: the report will be released Monday, Dec. 29, 2025, due to closure of the federal government.

If official data is delayed, traders may lean more heavily on:

  • private estimates
  • company commentary
  • shipping and sanctions headlines

That can make the oil tape—and energy stocks like Exxon—more sensitive to headlines than hard weekly statistics.


Bottom line for XOM heading into Tuesday’s open

Exxon Mobil stock ended Dec. 22 higher and held steady after hours, with only a modest uptick in extended trading.
The main driver investors were reacting to today was a rebound in oil prices tied to Venezuela-related enforcement headlines, while company-specific items reinforced Exxon’s ongoing exploration and offshore development runway.

For Tuesday morning, the most likely “movers” are overnight crude direction, 8:30 a.m. ET macro data (GDP/corporate profits), and the holiday-week liquidity setup—not a late-breaking Exxon corporate update. Bureau of Economic Analysis+2NYSE+2

Stock Market Today

  • SpaceX IPO Receives Over $70 Billion in Retail Demand
    June 11, 2026, 10:07 AM EDT. SpaceX's initial public offering (IPO) has garnered more than $70 billion in orders from retail investors, sources said. This surge in demand positions the offering for a potentially record-breaking debut as it moves toward completion. The strong retail interest underscores SpaceX's significant appeal in equity markets and highlights investor confidence in its space exploration and satellite ventures.

Latest articles

Navan surges after guidance hike brings AI travel platform to fore

Navan surges after guidance hike brings AI travel platform to fore

11 June 2026
Navan shares soared 21.18% premarket to $25.29 after the company raised its fiscal 2027 revenue outlook to $907–$913 million and boosted its non-GAAP operating income forecast to $76–$80 million, citing strong enterprise demand and surging booking volume, even as GAAP losses and cash burn persist.
Quantum Cyber slips after QUCY drone unit plan raises dilution fears

Quantum Cyber slips after QUCY drone unit plan raises dilution fears

11 June 2026
Quantum Cyber unveiled plans for an Advanced Filament Manufacturing Division at its proposed Connecticut drone facility, aiming to supply its 3D-printer drone farm and sell EMP-hardened filament, as QUCY shares closed at $1.92 on June 10 and rose 3.65% premarket amid volatile, high-volume trading; investors now weigh execution risks, ongoing losses, and the need for fresh capital against the company’s strategic manufacturing pivot.
Alibaba Drops After Beijing Puts 618 Subsidies in the Spotlight

Alibaba Drops After Beijing Puts 618 Subsidies in the Spotlight

11 June 2026
Alibaba’s Hong Kong shares plunged 5.4% after Beijing regulators challenged Taobao and Tmall’s 6.18 shopping festival discount claims, intensifying regulatory risk just as U.S.-listed shares had fallen for six straight sessions and raising investor concerns over profit margins and future promotions.
Salesforce Stock (CRM) After Hours on Dec. 22, 2025: Shares Hold Near $265 After Evercore’s 2026 Top-Pick Call — What to Know Before the Dec. 23 Market Open
Previous Story

Salesforce Stock (CRM) After Hours on Dec. 22, 2025: Shares Hold Near $265 After Evercore’s 2026 Top-Pick Call — What to Know Before the Dec. 23 Market Open

FDA Approves Wegovy Pill: Novo Nordisk’s Oral Semaglutide Launch Ignites a 2026 Weight‑Loss Drug Showdown
Next Story

FDA Approves Wegovy Pill: Novo Nordisk’s Oral Semaglutide Launch Ignites a 2026 Weight‑Loss Drug Showdown

Go toTop